Physician profile
Wayne P Cockrell
NPI 1053347823
$3,454.01
in general payments reported to CMS, 2019-2025
25 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.04 · 2020: $389 · 2021: $602 · 2022: $823 · 2023: $223 · 2024: $578 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $760.20 | 2021-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $684.46 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $362.23 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $314.71 | 2019-2024 | Xtampza |
| Abbott Laboratories | $212.38 | 2020-2025 | Eterna, Proclaim |
| Forte Bio-Pharma LLC | $198.83 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Globus Medical, INC. | $187.32 | 2025 | Senza, Omnia |
| Medtronic, INC. | $103.75 | 2021-2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $85.99 | 2019-2022 | |
| Pacira Therapeutics, INC. | $80.60 | 2020-2021 | |
| Medtronic USA, INC. | $70.20 | 2020 | |
| Valinor Pharma, LLC | $60.65 | 2024-2025 | Movantik |
| Scilex Pharmaceuticals INC. | $58.11 | 2020-2023 | Ztlido |
| Arbor Pharmaceuticals, INC. | $42.73 | 2021 | |
| Painteq LLC | $35.81 | 2023 | Painteq |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $35.53 | 2021 | |
| Ferring Pharmaceuticals INC. | $23.88 | 2025 | Euflexxa |
| Biotronik Nro, INC. | $22.76 | 2025 | Prospera |
| Curonix LLC | $21.14 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $19.14 | 2022 | |
| Bioventus LLC | $18.36 | 2020 | |
| Smith+Nephew, INC. | $16.70 | 2024 | Fast-Fix |
| Astrazeneca Pharmaceuticals Lp | $13.85 | 2020 | |
| Allergan, INC. | $13.63 | 2021 | |
| Amgen INC. | $11.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Cockrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.